HomeRLYB • NASDAQ
add
Rallybio Corp
Previous close
$0.33
Day range
$0.33 - $0.38
Year range
$0.22 - $1.89
Market cap
14.57M USD
Avg Volume
163.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 212.00K | — |
Operating expense | 9.88M | -40.06% |
Net income | -9.44M | 50.40% |
Net profit margin | -4.45K | — |
Earnings per share | -0.21 | 55.32% |
EBITDA | -9.64M | 41.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 54.50M | -42.13% |
Total assets | 57.98M | -41.64% |
Total liabilities | 3.91M | -61.67% |
Total equity | 54.07M | — |
Shares outstanding | 41.61M | — |
Price to book | 0.25 | — |
Return on assets | -38.35% | — |
Return on capital | -41.68% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.44M | 50.40% |
Cash from operations | -10.20M | 33.98% |
Cash from investing | 11.08M | 7.96% |
Cash from financing | — | — |
Net change in cash | 876.00K | 116.87% |
Free cash flow | -6.99M | -1.66% |
About
Founded
2018
Headquarters
Website
Employees
24
